We are pleased to share two exciting announcements for the Genome Stability Program (GSP) at UPMC Hillman Cancer Center.
First is the selection of Roddy O’Sullivan, PhD, as the next co-leader of the GSP. In this role, Dr. O’Sullivan will help to provide oversight for the development, direction, and coordination of the goals and specific aims of the program. Dr. O’Sullivan holds a position as Associate Professor in the Department of Pharmacology and Chemical Biology at Pitt. His lab conducts research into proteins that alter the structural and epigenetic functions of human telomeres.
In addition, Orlando Schärer, PhD, has been recognized as a Senior Leader within the GSP. He will serve as the chairman of the program’s faculty recruitment committee.
